Metropolitan Life Insurance Company (MetLife)’s Agenus AGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-484
| Closed | -$5.62K | – | 65 |
|
|
2024
Q1 | $5.62K | Buy |
484
+11
| +2% | +$146 | ﹤0.01% | 2242 |
|
|
2023
Q4 | $7.84K | Sell |
473
-466
| -50% | -$7.72K | ﹤0.01% | 2247 |
|
|
2023
Q3 | $21.2K | Hold |
939
| – | – | ﹤0.01% | 1866 |
|
|
2023
Q2 | $30.1K | Buy |
939
+95
| +11% | +$3.04K | ﹤0.01% | 1713 |
|
|
2023
Q1 | $25.2K | Sell |
844
-117
| -12% | -$4.94K | ﹤0.01% | 1763 |
|
|
2022
Q4 | $45.3K | Buy |
961
+91
| +10% | +$4.63K | ﹤0.01% | 1537 |
|
|
2022
Q3 | $35K | Buy |
870
+415
| +91% | +$21.2K | ﹤0.01% | 1701 |
|
|
2022
Q2 | $17.3K | Sell |
455
-285
| -39% | -$10.3K | ﹤0.01% | 2110 |
|
|
2022
Q1 | $35.7K | Sell |
740
-1,495
| -67% | -$80.8K | ﹤0.01% | 1779 |
|
|
2021
Q4 | $141K | Sell |
2,235
-91
| -4% | -$7.17K | ﹤0.01% | 2255 |
|
|
2021
Q3 | $240K | Sell |
2,326
-446
| -16% | -$50.4K | ﹤0.01% | 1939 |
|
|
2021
Q2 | $299K | Buy |
2,772
+1,499
| +118% | +$112K | ﹤0.01% | 1863 |
|
|
2021
Q1 | $68K | Sell |
1,273
-961
| -43% | -$69.4K | ﹤0.01% | 2510 |
|
|
2020
Q4 | $139K | Buy |
2,234
+25
| +1% | +$1.85K | ﹤0.01% | 2181 |
|
|
2020
Q3 | $173K | Sell |
2,209
-66
| -3% | -$5.13K | ﹤0.01% | 1862 |
|
|
2020
Q2 | $175K | Buy |
2,275
+402
| +21% | +$24.1K | ﹤0.01% | 1887 |
|
|
2020
Q1 | $90.1K | Sell |
1,873
-14
| -0.7% | -$879 | ﹤0.01% | 2095 |
|
|
2019
Q4 | $151K | Buy |
1,887
+1,055
| +127% | +$70.8K | ﹤0.01% | 2098 |
|
|
2019
Q3 | $42.1K | Sell |
832
-887
| -52% | -$47.5K | ﹤0.01% | 2510 |
|
|
2019
Q2 | $101K | Hold |
1,719
| – | – | ﹤0.01% | 2302 |
|
|
2019
Q1 | $100K | Buy |
1,719
+1
| +0.1% | +$62 | ﹤0.01% | 2321 |
|
|
2018
Q4 | $80.3K | Buy |
+1,718
| New | +$71.7K | ﹤0.01% | 2410 |
|
|
2018
Q2 | – | Sell |
-1,251
| Closed | -$116K | – | 2448 |
|
|
2018
Q1 | $116K | Buy |
1,251
+82
| +7% | +$7.28K | ﹤0.01% | 2222 |
|
|
2017
Q4 | $75K | Sell |
1,169
-1,665
| -59% | -$127K | ﹤0.01% | 2420 |
|
|
2017
Q3 | $245K | Sell |
2,834
-15
| -0.5% | -$1.22K | ﹤0.01% | 2165 |
|
|
2017
Q2 | $219K | Hold |
2,849
| – | – | ﹤0.01% | 2283 |
|
|
2017
Q1 | $211K | Buy |
2,849
+311
| +12% | +$24.6K | ﹤0.01% | 2232 |
|
|
2016
Q4 | $205K | Sell |
2,538
-27
| -1% | -$2.65K | ﹤0.01% | 2337 |
|
|
2016
Q3 | $361K | Sell |
2,565
-263
| -9% | -$30.2K | ﹤0.01% | 1924 |
|
|
2016
Q2 | $225K | Sell |
2,828
-1,143
| -29% | -$89.1K | ﹤0.01% | 2240 |
|
|
2016
Q1 | $324K | Buy |
3,971
+1,437
| +57% | +$96.9K | ﹤0.01% | 1852 |
|
|
2015
Q4 | $226K | Hold |
2,534
| – | – | ﹤0.01% | 2169 |
|
|
2015
Q3 | $229K | Hold |
2,534
| – | – | ﹤0.01% | 2196 |
|
|
2015
Q2 | $429K | Buy |
+2,534
| New | +$360K | ﹤0.01% | 1848 |
|
|
2015
Q1 | – | Sell |
-2,627
| Closed | -$205K | – | 2222 |
|
|
2014
Q4 | $205K | Hold |
2,627
| – | – | ﹤0.01% | 2398 |
|
|
2014
Q3 | $160K | Hold |
2,627
| – | – | ﹤0.01% | 2522 |
|
|
2014
Q2 | $166K | Buy |
+2,627
| New | +$152K | ﹤0.01% | 2614 |
|
Other funds holding AGEN
AG
DTC
Metropolitan Life Insurance Company (MetLife)'s AGEN Position: Q2 2024 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Agenus (AGEN) in Q2 2024, closing a stake of 484 shares — an estimated $5.62K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in AGEN in Q2 2014 and held it in 37 quarters. The position peaked at $429K in Q2 2015. 89 funds tracked by Wall St. Rank hold AGEN as of Q2 2024.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Agenus position as of Q2 2024 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 484 Agenus shares in Q2 2024, an estimated $5.62K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Agenus in Q2 2014 and held it in 37 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Agenus position peaked at $429K in Q2 2015.
- 89 funds tracked by Wall St. Rank held Agenus as of Q2 2024.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.